[REGN] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
07-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 18.28%
YoY- -3.46%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 3,414,400 4,951,700 2,422,900 2,169,500 1,927,800 1,582,447 1,226,827 18.59%
PBT 1,324,700 2,503,400 1,224,600 889,800 676,200 554,767 341,527 25.33%
Tax 127,600 274,400 75,400 97,800 -144,200 381,248 88,412 6.30%
NP 1,197,100 2,229,000 1,149,200 792,000 820,400 173,519 253,115 29.54%
Tax Rate -9.63% -10.96% -6.16% -10.99% 21.33% -68.72% -25.89% -
Total Cost 2,217,300 2,722,700 1,273,700 1,377,500 1,107,400 1,408,928 973,712 14.69%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 35.06 45.01 47.43 36.51 42.56 10.97 20.63 9.23%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS 11.19 20.99 10.90 7.25 7.58 1.62 2.41 29.14%
EPS Diluted 10.50 19.69 10.24 6.93 7.15 1.49 2.19 29.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.